Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab. Chen TL, Ma SH. J Am Acad Dermatol 2024 Aug 6:S0190-9622(24)02573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen TL, Ma SH. Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab. J Am Acad Dermatol 2024 Aug 6:S0190-9622(24)02573.
PMID: 39111594